The article offers information on the updated evidence reviews on screening and treatment for prostate cancer initiated by the U.S. Preventive Services Task Force (USPSTF) wherein screening results have been associated with harms related to subsequent evaluation and treatments.Reed...
“The USPSTF recommends individualized decision-making about screening for prostate cancer after discussion with a clinician, so that each man has an opportunity to understand the potential benefits and harms of screening and to incorporate his values and preferences into his decision.” The draft reco...
Hoffman, MD, MPH JAMA Internal Medicine Editorial USPSTF Prostate Cancer Screening Recommendations—A Step in the Right Direction Peter R. Carroll, MD, MPH JAMA Surgery Editorial A New Prostate Cancer Screening Recommendation Anita D. Misra-Hebert, MD, MPH; Michael W. Kattan, PhD JAMA Oncology ...
Carroll, MD, MPH JAMA Surgery Editorial A New Prostate Cancer Screening Recommendation Anita D. Misra-Hebert, MD, MPH; Michael W. Kattan, PhD JAMA Oncology US Preventive Services Task Force USPSTF Recommendation: Screening for Prostate Cancer US Preventive Services Task Force; David C. Grossman, ...
screening for men at higher risk. The USPSTF concluded that the evidence is limited on the benefit of screening among men older than 70 years, thus, providing a grade D recommendation against PSA-based screening for prostate cancer in men 70 years and older. The USPSTF further concluded that ...
Prostate cancer incidence and PSA testing patterns in relation to USPSTF screening recommendations. JAMA 314, 2054–2061 (2015). Article CAS Google Scholar Li, J., Berkowitz, Z. & Hall, I. J. Decrease in prostate cancer testing following the US preventive services task force (USPSTF) ...
In 2012, in the light that the 13-year PLCO trial revealed a negative benefit/risk balance of PSA testing [4], the US Preventive Services Task Force (USPSTF) released a strong position statement against screening [8]. Since the publication of the PLCO study, scientific societies have released...
In 2011 the United States Preventive Services Task Force (USPSTF) strongly advise against PSA screening based on a review of six well-done trials, underlying harms related to subsequent evaluation and treatments [5]. Nevertheless, several studies showed the evidence that screening reduces the risk ...
In its recommendation, the USPSTF noted that when a man has an elevated PSA, it may be caused by prostate cancer, but it could also be caused by other conditions, such as an enlarged prostate or an inflammation of the prostate. PSA–based scree...
Bad advice.From 2012 to 2018, the U.S. Preventive Services Task Force (USPSTF) said they didn’t think the PSA test should be used for routine prostate cancer screening. That’s a blood test commonly used to detect early signs of prostate cancer. They’ve changed their guidance since then...